# Optimising Renal Tumour Management Through Artificial Intelligence Modules

> **NCT06714916** · — · RECRUITING · sponsor: **Shao Pengfei** · enrollment: 2100 (estimated)

## Conditions studied

- Renal Neoplasms
- Pathology
- Renal Cell Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06714916
- **Lead sponsor:** Shao Pengfei
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-01
- **Primary completion:** 2028-01-01
- **Final completion:** 2033-12-31
- **Target enrollment:** 2100 (ESTIMATED)
- **Last updated:** 2025-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06714916

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06714916, "Optimising Renal Tumour Management Through Artificial Intelligence Modules". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06714916. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*